MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Viridian Therapeutics, Inc. Common Stock

VRDN

#3856
Viridian Therapeutics, Inc. Common Stock
29.3800
+2.98%
Sector:
Base:
Profit Currency:
Daily Range
29.3800
29.3800
Year Range
22.1050
34.2900
Daily Change
+2.98%
Monthly Change
-12.59%
6 month change
+30.87%
Year Change
+30.87%
Previous Close
28.5300
Open
29.3800
Bid
Ask
Low
29.3800
High
29.3800
Volume
105
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. VRDN
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

News

Investing Investing
VRDN
2 days ago, 20:48
Stifel reiterates Viridian Therapeutic stock rating on BLA review
Investing Investing
VRDN
2 days ago, 16:26
Jefferies raises Viridian Therapeutic stock price target on trial progress
Investing Investing
VRDN
2 days ago, 15:45
Evercore ISI reiterates Viridian Therapeutic stock rating on data conviction
Zacks Zacks
VRDN CDXS
2 days ago, 14:55
Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Misses Revenue Estimates
Investing Investing
VRDN
2 days ago, 14:19
Viridian Therapeutics earnings missed by $0.10, revenue fell short of estimates
Zacks Zacks
MDXG VRDN
2 days ago, 00:25
MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates
Investing Investing
VRDN
2026.02.18
Truist reiterates Viridian Therapeutic stock rating ahead of trial
Investing Investing
VRDN
2026.01.28
Evercore ISI raises Viridian Therapeutics stock price target on subQ TED potential
Seeking Alpha Seeking Alpha
VRDN AMGN
2026.01.26
Viridian Therapeutics: Cautious Optimism As Key Milestones Approach (Downgrade) (VRDN)
Investing Investing
VRDN
2026.01.14
Viridian Therapeutics stock hits 52-week high at $34.06
Investing Investing
AMGN VRDN
2026.01.07
UBS initiates Viridian Therapeutic stock with Buy rating on TED treatment
Investing Investing
VRDN
2026.01.06
Viridian Therapeutic stock a Top Pick at TD Cowen ahead of busy 2026

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd